Antitumor Activity of a Novel Oncrasin Analogue Is Mediated by JNK Activation and STAT3 Inhibition
Wei Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Bingliang Fang(The University of Texas MD Anderson Cancer Center)
Cited by 32
Related Papers
Mouse Embryonic Head as a Site for Hematopoietic Stem Cell Development
|Cell stem cell|2012|192
Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells
|Oncotarget|2015|147
Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non‐small cell lung cancer patients with neoadjuvant immunotherapy
|Cancer Science|2023|90